Navigation Links
NC State scientist finds soft tissue in T. rex bones

r group, Schweitzer compared the findings from the T. rex with structures found in modern-day ostriches. In both samples, transparent branching blood vessels were present, and many of the small microstructures present in the T. rex sample displayed the same appearance as the blood and bone cells from the ostrich sample.

Schweitzer then duplicated her findings with at least three other well-preserved dinosaur specimens, one 80-million-year-old hadrosaur and two 65-million-year-old tyrannosaurs. All of these specimens preserved vessels, cell-like structures, or flexible matrix that resembled bone collagen from modern specimens.

Current theories about fossil preservation hold that organic molecules should not preserve beyond 100,000 years. Schweitzer hopes that further research will reveal exactly what the soft structures isolated from these bones are made of. Do they consist of the original cells, and if so, do the cells still contain genetic information? Her early studies of the material suggest that at least some fragments of the dinosaurs' original molecular material may still be present.

"We may not really know as much about how fossils are preserved as we think," says Schweitzer. "Our preliminary research shows that antibodies that recognize collagen react to chemical extracts of this fossil bone. If further studies confirm this, we may have the potential to learn more not only about the dinosaurs themselves, but also about how and why they were preserved in the first place."

The research was funded by NC State, the N.C. Museum of Natural Sciences and the National Science Foundation.

"Soft-Tissue Vessels and Cellular Preservation in Tyrannosaurus rex"
Authors: Mary H. Schweitzer and Jennifer L. Wittmeyer, North Carolina State University; John R. Horner, Montana State University; Jan B. Toporski, Carnegie Institution of Washington Geophysical Laboratory Published: March 25, 2005, in Science


'"/>

Source:North Carolina State University


Page: 1 2

Related biology news :

1. K-State professors discover enzyme responsible for creation of a beetles hard shell
2. NC State researchers redesign life for Mars and beyond
3. K-State researchers study insects immune system
4. K-State researchers study gene regulation in insects
5. K-Staters design and build a low-cost remote sensing tool for environmental studies
6. Iowa State researchers improving plastics made from corn and soy proteins
7. Investment level in HIV prevention programs related to HIV incidence in the United States
8. Iowa State University botanists identify new species of North American bamboo
9. ConocoPhillips establishes $22.5M biofuels research program at Iowa State
10. Iowa State scientists demonstrate first use of nanotechnology to enter plant cells
11. Wisconsin scientists grow critical nerve cells
Post Your Comments:
Breaking Biology Technology:BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5